Glow Lifetech Corp.·Healthcare

Toronto, Ontario--(Newsfile Corp. - May 26, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to report its financial results for the first quarter ended March 31, 2026 ("Q1 2026"). In Q1 2026, Glow delivered strong revenue growth, sustained high gross margins, improved operating efficiency, and strengthened its balance sheet, reflecting continued commercial momentum and progress toward sustainable profitability.

Toronto, Ontario--(Newsfile Corp. - April 30, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to provide a commercial update highlighting continued expansion of its retail distribution network, new product innovation, and progress advancing its national growth strategy. MOD™ Expands into Two of Canada's Largest Cannabis Retailers Building on Glow's recent success expanding distribution with Canada's leading national cannabis retailers, Glow has expanded distribution of its flagship MOD™ brand into two of Canada's largest cannabis retailers, adding approximately 140 new retail locations across Ontario.

Toronto, Ontario--(Newsfile Corp. - April 8, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to report its financial results for the fourth quarter and full year ended December 31, 2025 ("Q4 2025" and "FY 2025"). In FY 2025, Glow delivered record revenue and gross profit, sustained high gross margins, improved operating efficiency, and strengthened its balance sheet while achieving its second consecutive quarter of positive cash flow from operations.

Toronto, Ontario--(Newsfile Corp. - March 27, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce a significant reduction in its outstanding share purchase warrants and stock options during the first quarter of 2026, marking an important milestone in the Company's ongoing efforts to further simplify its capital structure and reduce potential dilution. Significant Reduction in Warrant and Option Overhang During Q1 2026, the Company reduced a total of 41,031,673 share purchase warrants1 and 5,025,000 stock options, building on a series of previous balance sheet improvements in 2025.
Glow Lifetech Corp., a biotechnology company, focuses on producing nutraceutical and cannabinoid-based products in North America. The company engages in the commercialization of two technologies, such as MyCell Enhanced technology, a nutraceutical and cannabis nutrient delivery technology; and a cannabis Smart Consumption System to assist users and patients to store, journal, control, consume, and manage cannabis related products. The company has the exclusive North American rights for the production, sale, and distribution rights for the certain micellization technology for cannabis and hemp derived ingredients, curcumin, vitamin K, and iron. It also engages in the business of secondary processing of ingredients to produce micellized materials from certain vitamins, nutraceuticals, and cannabis extracts that makes fat-soluble substances available for immediate absorption into the body reach near 100% bioavailability and water compatibility. The company was incorporated in 2018 and is based in Toronto, Canada.